Chung Sung-Jun/Getty Images
There has been a lot of noise about how DRAM and NAND pricing is about to collapse and companies that are focused on those chips are about to see their share prices collapse as well.
Most recent was the bear case from Goldman Sachs which laid out the argument that companies in the space like Micron, Western Digital and company were not worthy of an investment at current levels since DRAM and NAND prices were at their peak and this was the best it can get.
Incidentally shares of Micron finished higher on the week despite the downgrade from Goldman Sachs, albeit by a small amount. Micron finished last week up 2.6% at $28.93 per share despite Goldy taking its rating from a Buy to a Neutral and its accompanying price target down to $30 per share from $32 per share.
The reasons to remain optimistic if not even more optimistic on the DRAM/NAND makers are two fold with the primary rationale being the massive global buildout of datacenters. If one merely scans the headlines, he/she will find announcements almost weekly from the likes of Google, Amazon, Alibaba, Tencent and Baidu talking about the setting up a new datacenter.
Hot Safest Stocks To Invest In Right Now: BB&T Corporation(BBT)
- [By Ben Levisohn]
We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).
Hot Safest Stocks To Invest In Right Now: Arena Pharmaceuticals, Inc.(ARNA)
- [By Lisa Levin]
Shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) were down around 18 percent to $1.22. Arena Pharmaceuticals priced its 60 million share offering at $1.15 per share.
- [By Keith Speights]
Eisai partnered with Arena Pharmaceuticals (NASDAQ:ARNA) several years ago on obesity drug Belviq. The drug won U.S. regulatory approval in 2012, but sales have been underwhelming. As a result, Arena sold Belviq to Eisai earlier this year.
- [By Peter Graham]
The Q4 2016 earnings report for small cap obesity drug stock Arena Pharmaceuticals, Inc (NASDAQ: ARNA) is scheduled for after the market closes onTuesday (March 14th). Last June,Arena Pharmaceuticals announced a strategic shifting of priorities to emphasize its proprietary clinical stage pipeline and the implementation of additional cost reductions to streamline the organization to support its development programs. Among the actions to be taken is the layoff of 73% of the companys workforce which will cost approximately $6.1 million.
Hot Safest Stocks To Invest In Right Now: Kalytera Therapeutics, Inc. (QUEZF)
- [By Javier Hasse]
Kalytera Therapeutics Inc (OTC: QUEZF) closed a C$13.4 million ($10.2 million) tranche of a private placement for the acquisition of Talent Biotechs Ltd.
Hot Safest Stocks To Invest In Right Now: Gas Natural Inc.(EGAS)
- [By Monica Gerson]
Gas Natural Inc (NYSE: EGAS) is projected to post its quarterly earnings at $0.23 per share.
Caleres Inc (NYSE: CAL) is expected to post its quarterly earnings at $0.23 per share on revenue of $632.89 million.